Clinical Trial Update: Endometrial Thickness and Subendometrial Vascularity in Anovulatory Polycystic Ovarian Syndrome Patients Treated by Metformin [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 clinical trial evaluating endometrial thickness and subendometrial vascularity in anovulatory PCOS patients treated with metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Polycystic Ovary Syndrome, Anovulatory | Phase 4 | Status: UNKNOWN